Yaser Mohammed Al-Worafi
Elsevier Science
e druk, 2020
9780128198377
Drug Safety in Developing Countries
Achievements and Challenges
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
2020
ISBN13: 9780128198377
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries.
Specificaties
Inhoudsopgave
<p>Section 1 Drug safety-related issues<br>1. Introduction: Why do we need a book on drug safety in developing countries?<br>2. Medications safety-related terminology<br>3. Medications registration and marketing: safety-related issues<br>4. Pharmacovigilance<br>5. Adverse drug reactions<br>6. Medication errors<br>7. Self-medication<br>8. Antibiotics safety issue<br>9. Drug-related problems<br>10. Counterfeit and substandard medications<br>11. Medication abuse and misuse<br>12. Storage and disposal of medications<br>13. Safety of medications in special population<br>14. Herbal medicines safety issues<br>15. Medications safety resources and tools<br>16. Medications safety pharmacoeconomics-related issues<br>17. Evidence-based medications safety practice<br>18. Technology in medications safety<br>19. Medications safety research issues<br>20. Quality indicators for medications safety</p> <p>Section 2: Drug Safety in Asia<br>21. Drug safety in Malaysia <br>22. Drug safety in Thailand<br>23. Drug safety in Indonesia<br>24. Drug safety in Pakistan<br>25. Drug safety in India<br>26. Drug safety in Nepal<br>27. Drug safety in Sri Lanka<br>28. Drug Safety in China</p> <p>Section 3: Drug Safety in Middle East <br>29. Drug safety in Yemen<br>30. Drug safety in Saudi Arabia<br>31. Drug safety in UAE<br>32. Drug safety in Jordan<br>33. Drug safety in Lebanon<br>34. Drug safety in Palestine<br>35. Drug safety in Qatar</p> <p>Section 4: Drug Safety in Africa<br>36. Drug safety in Sudan<br>37. Drug safety in Egypt<br>38. Drug safety in Nigeria<br>39. Drug safety in Mali<br>40. Drug safety in Burkina Faso</p> <p>Section 5: Drug Safety in Latin America<br>41. Drug safety in Chile</p> <p>Section 6: Comparisons and conclusions <br>42. Compare between the developing countries<br>43. Drug Safety in Developing Versus Developed countries<br></p>